Search for Clinical Trial Results

Sponsored By

Papillary Renal Cell Carcinoma - 25 Studies Found

Status Study
Recruiting Study Name: Axitinib in1st Line Treatment for Patients With Advanced or Metastatic Papillary Renal Cell Carcinoma
Condition: Papillary Renal Cell Carcinoma
Date: 2015-06-19
Interventions: Drug: axitinib Other Name: Inlyta
Recruiting Study Name: Vandetanib in Combination With Metformin in People With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell Carcinoma
Condition:
  • Renal Cell Carcinoma
  • Hereditary Leiomyomatosis and Renal Cell Cancer
  • Drug: Vandetanib Vandetanib is
Recruiting Study Name: A Phase 2 Study of the MET Kinase Inhibitor INC280 in Papillary Renal Cell Cancer
Condition: Papillary Renal Cell Carcinoma
Date: 2013-12-20
Interventions: Drug: INC280 Supplied by Novartis as film-coated tablet for oral use.
Completed Study Name: A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC)
Condition: Carcinoma, Renal Cell
Date: 2008-07-29
Interventions: Drug: foretinib (formerly GSK1363089 or XL880) treatment with oral foretinib on one of 2 dosing regimens
Active, not recruiting Study Name: A Phase II Trial to Evaluate the Efficacy of AZD6094 (HMPL-504) in Patients With Papillary Renal Cell Carcinoma (PRCC)
Condition: Papillary Renal Cell Cancer
Date: 2014-04-23
Interventions: Drug: AZD6094 AZD6094 is a potent and selective small molecule cMet kinase inhibitor.
Active, not recruiting Study Name: Tivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot Be Removed by Surgery
Condition:
  • Recurrent Renal Cell Carcinoma
  • Stage III Renal Cell Cancer
  • Date: 2012-09-14
    Interventions:
    • Drug: Erlotinib Hydrochloride

Completed Study Name: Efficacy Trial of the Implantation of Mouse Renal Adenocarcinoma Macrobeads in Subjects With Castration-Resistant Prostate Cancer Resistant to Taxanes (Docetaxel, Cabazitaxel) and Evidence of Disease Progression on Androgen-axis Inhibition and/or Immunotherapy in the Form of Sipuleucel-T
Condition: Prostate Cancer
Date: 2010-08-01
Interventions: Biological: Cancer Macrobead placement in abdominal cavity 8 macrobeads per kilogram
Terminated Study Name: Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney Cancer
Condition: Kidney Cancer
Date: 2008-01-22
Interventions: Biological: bevacizumab 15 mg/kg over 90 minutes every 3 weeks
Terminated Study Name: Sunitinib as First-Line Therapy in Treating Patients With Locally Advanced Metastatic Papillary Renal Cell Cancer
Condition: Kidney Cancer
Date: 2007-10-05
Interventions: Drug: sunitinib malate
Completed Study Name: Sunitinib in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer
Condition: Kidney Cancer
Date: 2007-04-11
Interventions: Drug: sunitinib malate
Next >>>